AA
AZN icon

Addison Advisors’s AstraZeneca AZN Stock Holding History

Addison Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5K Sell
240
-625
-72% -$118K 0.02% 258
2026
Q1 		$171K Sell
865
-3
-0.3% -$578 0.04% 241
2025
Q4 		$160K Buy
868
+32
+4% +$5.61K 0.04% 253
2025
Q3 		$128K Buy
836
+69
+9% +$10.4K 0.03% 282
2025
Q2 		$107K Sell
767
-121
-14% -$17K 0.03% 301
2025
Q1 		$130K Buy
888
+21
+2% +$3.04K 0.04% 262
2024
Q4 		$114K Sell
867
-5
-0.6% -$700 0.03% 283
2024
Q3 		$136K Buy
872
+93
+12% +$15K 0.04% 266
2024
Q2 		$121K Buy
779
+248
+47% +$37.3K 0.04% 265
2024
Q1 		$72K Buy
531
+33
+7% +$4.37K 0.02% 321
2023
Q4 		$67.1K Buy
498
+133
+36% +$17.3K 0.03% 317
2023
Q3 		$49.4K Buy
365
+116
+47% +$15.8K 0.02% 322
2023
Q2 		$35.6K Buy
249
+17
+7% +$2.5K 0.02% 358
2023
Q1 		$32.1K Sell
232
-19
-8% -$2.56K 0.02% 348
2022
Q4 		$34K Sell
251
-202
-45% -$25.3K 0.02% 321
2022
Q3 		$50K Buy
453
+16
+4% +$2.03K 0.03% 262
2022
Q2 		$58K Sell
437
-107
-20% -$14K 0.04% 242
2022
Q1 		$72K Buy
544
+267
+96% +$32K 0.04% 238
2021
Q4 		$32K Buy
277
+260
+1,529% +$30.6K 0.02% 283
2021
Q3 		$2K Buy
17
+8
+89% +$931 ﹤0.01% 371
2021
Q2 		$1K Buy
+9
New +$987 ﹤0.01% 376
2020
Q4 		$1K Buy
+9
New +$953 ﹤0.01% 361

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Addison Advisors's AZN Position: Q2 2026 in Review

Addison Advisors reduced its AstraZeneca (AZN) stake by 72% in Q2 2026, selling an estimated $118K and leaving 240 shares worth $45.5K. The position accounts for 0.02% of the portfolio, ranked #258.

Addison Advisors first reported a position in AZN in Q4 2020 and has held it in 22 quarters since. The position peaked at $171K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Addison Advisors held 240 shares of AstraZeneca worth $45.5K as of Q2 2026.
  • Addison Advisors sold 625 AstraZeneca shares in Q2 2026, an estimated $118K.
  • AstraZeneca made up 0.02% of Addison Advisors's portfolio in Q2 2026, its #258 holding.
  • Addison Advisors first reported a position in AstraZeneca in Q4 2020 and has held it in 22 quarters since.
  • Addison Advisors's AstraZeneca position peaked at $171K in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.